BELITE BIO INC - AMER
81.08
08-نوفمبر-24 15:59:58
15 متأخرة بدقائق
الأسهم
-1.31
-1.59%
نطاق اليوم
79.71 - 83.60
ISIN
N/A
المصدر
NASDAQ
-
25 أبريل 2023 16:30:00 بحسب Nasdaq GlobeNewswire
-
11 أبريل 2023 09:00:01 بحسب Nasdaq GlobeNewswire
-
Belite Bio Reports Full-Year 2022 Operational Highlights and Financial Results
31 مارس 2023 19:03:37 بحسب Nasdaq GlobeNewswire
-
Belite Bio to Host Webcast on April 3, 2023 to Discuss 2022 Full Year Financial Results
31 مارس 2023 12:57:14 بحسب Nasdaq GlobeNewswire
-
18 نوفمبر 2022 08:00:00 بحسب Nasdaq GlobeNewswire
-
Belite Bio to Host Key Opinion Leader Webinar on October 27, 2022 to discuss LBS-008 Interim Data
20 أكتوبر 2022 08:00:01 بحسب Nasdaq GlobeNewswire
-
01 أكتوبر 2022 19:03:33 بحسب Nasdaq GlobeNewswire
-
23 سبتمبر 2022 08:00:00 بحسب Nasdaq GlobeNewswire
-
Belite Bio Receives Approval of LBS-008 Phase 3 Clinical Trial in China
16 سبتمبر 2022 08:00:32 بحسب Nasdaq GlobeNewswire
-
Belite Bio Initiates Pivotal Phase 3 Clinical Trial of LBS-008 in Stargardt Disease in the U.S.
22 أغسطس 2022 08:00:00 بحسب Nasdaq GlobeNewswire
-
Belite Bio Reports First Half 2022 Operational Highlights and Financial Results
10 أغسطس 2022 21:51:10 بحسب Nasdaq GlobeNewswire
-
Belite Bio to Host Conference Call on August 11, 2022 to Discuss First Half 2022 Financial Results
01 أغسطس 2022 16:10:00 بحسب Nasdaq GlobeNewswire
-
19 يوليو 2022 16:05:33 بحسب Nasdaq GlobeNewswire
-
Belite Bio Announces Partial Exercise of Over-Allotment Option in Initial Public Offering
12 مايو 2022 16:30:00 بحسب Nasdaq GlobeNewswire
-
05 مايو 2022 08:00:02 بحسب Nasdaq GlobeNewswire
-
Belite Bio Announces Closing of $36 Million Initial Public Offering
03 مايو 2022 16:30:00 بحسب Nasdaq GlobeNewswire
-
Belite Bio Receives FDA Fast Track Designation For LBS-008
03 مايو 2022 06:50:00 بحسب Nasdaq GlobeNewswire